Xiamen Tungsten Co.,Ltd. (SHA:600549)

CTI BioPharma Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	36,070	30,595	24,366	27,731	32,100	23,692
Market Cap Growth	10.85%	25.56%	-12.13%	-13.61%	35.49%	29.22%
Enterprise Value	49,606	46,873	42,131	44,197	44,079	34,673
Last Close Price	22.72	18.89	16.48	18.41	21.03	15.54
PE Ratio	19.77	17.71	15.21	19.18	27.23	38.58
Forward PE	15.74	12.93	11.81	13.90	20.09	37.87
PS Ratio	1.02	0.87	0.62	0.57	1.01	1.25
PB Ratio	1.47	1.26	1.28	1.73	2.46	2.39
P/TBV Ratio	2.46	2.15	2.55	3.30	4.17	3.73
P/FCF Ratio	140.65	31.09	11.17	-	-	36.42
P/OCF Ratio	16.75	9.87	5.69	-	30.85	14.41
EV/Sales Ratio	1.41	1.33	1.07	0.92	1.38	1.83
EV/EBITDA Ratio	11.53	10.97	10.02	11.38	14.31	16.40
EV/EBIT Ratio	15.96	15.03	13.66	15.42	20.38	27.32
EV/FCF Ratio	193.43	47.62	19.31	-	-	53.30
Debt / Equity Ratio	0.47	0.60	0.78	0.87	1.15	0.87
Debt / EBITDA Ratio	2.70	3.38	3.50	3.56	4.84	4.07
Debt / FCF Ratio	45.38	14.76	6.80	-	-	13.21
Asset Turnover	0.82	0.83	1.00	1.33	1.10	0.78
Inventory Turnover	3.58	3.69	4.13	5.01	4.04	3.11
Quick Ratio	0.91	1.05	1.04	0.85	0.59	0.45
Current Ratio	1.54	1.68	1.84	1.45	1.17	0.91
Return on Equity (ROE)	11.60%	12.46%	14.33%	14.99%	14.74%	9.71%
Return on Assets (ROA)	4.53%	4.60%	4.87%	4.93%	4.66%	3.26%
Return on Capital (ROIC)	5.63%	5.36%	6.04%	6.17%	5.80%	4.29%
Return on Capital Employed (ROCE)	10.40%	10.00%	10.90%	11.80%	12.20%	10.10%
Earnings Yield	4.69%	5.65%	6.57%	5.21%	3.67%	2.59%
FCF Yield	0.71%	3.22%	8.96%	-7.55%	-1.03%	2.75%
Dividend Yield	1.81%	2.22%	2.43%	1.90%	1.24%	0.97%
Payout Ratio	54.05%	53.11%	59.15%	51.72%	54.35%	82.60%
Buyback Yield / Dilution	-4.24%	-1.25%	-0.35%	-0.00%	-0.01%	0.39%
Total Shareholder Return	-2.49%	0.97%	2.08%	1.90%	1.22%	1.35%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.